Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Shares Issued (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Shares Issued data on record, last reported at -$35.0 million in Q2 2025.

  • For Q2 2025, Shares Issued fell 1351.5% year-over-year to -$35.0 million; the TTM value through Sep 2025 reached $1.3 million, down 21.63%, while the annual FY2024 figure was $3.7 million, 877.49% up from the prior year.
  • Shares Issued reached -$35.0 million in Q2 2025 per FBIO's latest filing, down from $36.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $36.0 million in Q1 2025 and bottomed at -$35.0 million in Q2 2025.
  • Average Shares Issued over 5 years is $1.2 million, with a median of $559000.0 recorded in 2023.
  • The widest YoY moves for Shares Issued: up 119900.0% in 2025, down 1351.5% in 2025.
  • A 5-year view of Shares Issued shows it stood at $6.3 million in 2021, then crashed by 95.22% to $303000.0 in 2022, then crashed by 652.48% to -$1.7 million in 2023, then skyrocketed by 120.31% to $340000.0 in 2024, then tumbled by 10391.76% to -$35.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$35.0 million in Q2 2025, $36.0 million in Q1 2025, and $340000.0 in Q4 2024.